Publication Information

{'id': 'https://openalex.org/W2112515627', 'doi': 'https://doi.org/10.1248/bpb.34.66', 'title': 'Evidence for Time-Dependent Interactions between Ritonavir and Lopinavir/Ritonavir Plasma Levels Following P-Glycoprotein Inhibition in Sprague-Dawley Rats', 'display_name': 'Evidence for Time-Dependent Interactions between Ritonavir and Lopinavir/Ritonavir Plasma Levels Following P-Glycoprotein Inhibition in Sprague-Dawley Rats', 'publication_year': 2011, 'publication_date': '2011-01-01', 'ids': {'openalex': 'https://openalex.org/W2112515627', 'doi': 'https://doi.org/10.1248/bpb.34.66', 'mag': '2112515627', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/21212519'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1248/bpb.34.66', 'pdf_url': 'https://www.jstage.jst.go.jp/article/bpb/34/1/34_1_66/_pdf', 'source': {'id': 'https://openalex.org/S165235614', 'display_name': 'Biological and Pharmaceutical Bulletin', 'issn_l': '0918-6158', 'issn': ['0918-6158', '1347-5215'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313382', 'host_organization_name': 'Pharmaceutical Society of Japan', 'host_organization_lineage': ['https://openalex.org/P4310313382'], 'host_organization_lineage_names': ['Pharmaceutical Society of Japan'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://www.jstage.jst.go.jp/article/bpb/34/1/34_1_66/_pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5023162412', 'display_name': 'Michael du Plooy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I27765905', 'display_name': 'North-West University', 'ror': 'https://ror.org/010f1sq29', 'country_code': 'ZA', 'type': 'education', 'lineage': ['https://openalex.org/I27765905']}], 'countries': ['ZA'], 'is_corresponding': False, 'raw_author_name': 'Michael du Plooy', 'raw_affiliation_strings': ['Unit for Drug Research and Development, Division of Pharmacology, School of Pharmacy, North-West University, Potchefstroom, 2520, South Africa.'], 'affiliations': [{'raw_affiliation_string': 'Unit for Drug Research and Development, Division of Pharmacology, School of Pharmacy, North-West University, Potchefstroom, 2520, South Africa.', 'institution_ids': ['https://openalex.org/I27765905']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039217301', 'display_name': 'Michelle Viljoen', 'orcid': 'https://orcid.org/0000-0002-4406-3666'}, 'institutions': [{'id': 'https://openalex.org/I27765905', 'display_name': 'North-West University', 'ror': 'https://ror.org/010f1sq29', 'country_code': 'ZA', 'type': 'education', 'lineage': ['https://openalex.org/I27765905']}], 'countries': ['ZA'], 'is_corresponding': False, 'raw_author_name': 'Michelle Viljoen', 'raw_affiliation_strings': ['Unit for Drug Research and Development, Division of Pharmacology, School of Pharmacy, North-West University'], 'affiliations': [{'raw_affiliation_string': 'Unit for Drug Research and Development, Division of Pharmacology, School of Pharmacy, North-West University', 'institution_ids': ['https://openalex.org/I27765905']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5038350024', 'display_name': 'Malie Rheeders', 'orcid': 'https://orcid.org/0000-0001-7222-2663'}, 'institutions': [{'id': 'https://openalex.org/I27765905', 'display_name': 'North-West University', 'ror': 'https://ror.org/010f1sq29', 'country_code': 'ZA', 'type': 'education', 'lineage': ['https://openalex.org/I27765905']}], 'countries': ['ZA'], 'is_corresponding': False, 'raw_author_name': 'Malie Rheeders', 'raw_affiliation_strings': ['Unit for Drug Research and Development, Division of Pharmacology, School of Pharmacy, North-West University'], 'affiliations': [{'raw_affiliation_string': 'Unit for Drug Research and Development, Division of Pharmacology, School of Pharmacy, North-West University', 'institution_ids': ['https://openalex.org/I27765905']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.766, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 14, 'citation_normalized_percentile': {'value': 0.802365, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 87, 'max': 88}, 'biblio': {'volume': '34', 'issue': '1', 'first_page': '66', 'last_page': '70'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10570', 'display_name': 'Drug Transport and Resistance Mechanisms', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10570', 'display_name': 'Drug Transport and Resistance Mechanisms', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12229', 'display_name': 'Pharmacological Effects and Toxicity Studies', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/lopinavir', 'display_name': 'Lopinavir', 'score': 0.9712442}, {'id': 'https://openalex.org/keywords/ritonavir', 'display_name': 'Ritonavir', 'score': 0.9693531}, {'id': 'https://openalex.org/keywords/lopinavir/ritonavir', 'display_name': 'Lopinavir/ritonavir', 'score': 0.86985385}, {'id': 'https://openalex.org/keywords/p-glycoprotein', 'display_name': 'P-glycoprotein', 'score': 0.6544987}], 'concepts': [{'id': 'https://openalex.org/C2777182164', 'wikidata': 'https://www.wikidata.org/wiki/Q422585', 'display_name': 'Lopinavir', 'level': 5, 'score': 0.9712442}, {'id': 'https://openalex.org/C2779298103', 'wikidata': 'https://www.wikidata.org/wiki/Q422618', 'display_name': 'Ritonavir', 'level': 5, 'score': 0.9693531}, {'id': 'https://openalex.org/C2781392899', 'wikidata': 'https://www.wikidata.org/wiki/Q422618', 'display_name': 'Lopinavir/ritonavir', 'level': 5, 'score': 0.86985385}, {'id': 'https://openalex.org/C2777022698', 'wikidata': 'https://www.wikidata.org/wiki/Q410291', 'display_name': 'Verapamil', 'level': 3, 'score': 0.7386998}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.6975942}, {'id': 'https://openalex.org/C2778707650', 'wikidata': 'https://www.wikidata.org/wiki/Q412902', 'display_name': 'P-glycoprotein', 'level': 4, 'score': 0.6544987}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.6244521}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.4981606}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.33558664}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3055312}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.18013117}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.15968907}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.13107696}, {'id': 'https://openalex.org/C133936738', 'wikidata': 'https://www.wikidata.org/wiki/Q643839', 'display_name': 'Multiple drug resistance', 'level': 3, 'score': 0.077946395}, {'id': 'https://openalex.org/C501593827', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotics', 'level': 2, 'score': 0.07586932}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.073064774}, {'id': 'https://openalex.org/C519063684', 'wikidata': 'https://www.wikidata.org/wiki/Q706', 'display_name': 'Calcium', 'level': 2, 'score': 0.057671815}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D020168', 'descriptor_name': 'ATP Binding Cassette Transporter, Subfamily B, Member 1', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D014700', 'descriptor_name': 'Verapamil', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D020168', 'descriptor_name': 'ATP Binding Cassette Transporter, Subfamily B, Member 1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020168', 'descriptor_name': 'ATP Binding Cassette Transporter, Subfamily B, Member 1', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D019380', 'descriptor_name': 'Anti-HIV Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002121', 'descriptor_name': 'Calcium Channel Blockers', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D002121', 'descriptor_name': 'Calcium Channel Blockers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061466', 'descriptor_name': 'Lopinavir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D011744', 'descriptor_name': 'Pyrimidinones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017207', 'descriptor_name': 'Rats, Sprague-Dawley', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D019438', 'descriptor_name': 'Ritonavir', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014700', 'descriptor_name': 'Verapamil', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1248/bpb.34.66', 'pdf_url': 'https://www.jstage.jst.go.jp/article/bpb/34/1/34_1_66/_pdf', 'source': {'id': 'https://openalex.org/S165235614', 'display_name': 'Biological and Pharmaceutical Bulletin', 'issn_l': '0918-6158', 'issn': ['0918-6158', '1347-5215'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313382', 'host_organization_name': 'Pharmaceutical Society of Japan', 'host_organization_lineage': ['https://openalex.org/P4310313382'], 'host_organization_lineage_names': ['Pharmaceutical Society of Japan'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://hdl.handle.net/10394/7378', 'pdf_url': 'https://repository.nwu.ac.za/bitstream/10394/7378/1/Evidencefortime-dependent_pdf.pdf', 'source': {'id': 'https://openalex.org/S4306402268', 'display_name': 'Boloka Institutional Repository (North-west University)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I114027177', 'host_organization_name': 'University of North Carolina at Chapel Hill', 'host_organization_lineage': ['https://openalex.org/I114027177'], 'host_organization_lineage_names': ['University of North Carolina at Chapel Hill'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.jstage.jst.go.jp/article/bpb/34/1/34_1_66/_pdf/-char/en', 'pdf_url': 'https://www.jstage.jst.go.jp/article/bpb/34/1/34_1_66/_pdf/-char/en', 'source': {'id': 'https://openalex.org/S4306402268', 'display_name': 'Boloka Institutional Repository (North-west University)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I114027177', 'host_organization_name': 'University of North Carolina at Chapel Hill', 'host_organization_lineage': ['https://openalex.org/I114027177'], 'host_organization_lineage_names': ['University of North Carolina at Chapel Hill'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/21212519', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1248/bpb.34.66', 'pdf_url': 'https://www.jstage.jst.go.jp/article/bpb/34/1/34_1_66/_pdf', 'source': {'id': 'https://openalex.org/S165235614', 'display_name': 'Biological and Pharmaceutical Bulletin', 'issn_l': '0918-6158', 'issn': ['0918-6158', '1347-5215'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310313382', 'host_organization_name': 'Pharmaceutical Society of Japan', 'host_organization_lineage': ['https://openalex.org/P4310313382'], 'host_organization_lineage_names': ['Pharmaceutical Society of Japan'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.84, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 27, 'referenced_works': ['https://openalex.org/W1603442447', 'https://openalex.org/W1964470226', 'https://openalex.org/W1975396712', 'https://openalex.org/W1975545447', 'https://openalex.org/W1983544050', 'https://openalex.org/W1984475551', 'https://openalex.org/W1986596542', 'https://openalex.org/W1986680143', 'https://openalex.org/W1990043592', 'https://openalex.org/W2003623971', 'https://openalex.org/W2009053260', 'https://openalex.org/W2017691229', 'https://openalex.org/W2024773741', 'https://openalex.org/W2041486284', 'https://openalex.org/W2046814818', 'https://openalex.org/W2052371389', 'https://openalex.org/W2062881838', 'https://openalex.org/W2063392573', 'https://openalex.org/W2070739630', 'https://openalex.org/W2089671884', 'https://openalex.org/W2090474536', 'https://openalex.org/W2108992076', 'https://openalex.org/W2120336413', 'https://openalex.org/W2318022415', 'https://openalex.org/W2322143727', 'https://openalex.org/W37174246', 'https://openalex.org/W4241711879'], 'related_works': ['https://openalex.org/W2112515627', 'https://openalex.org/W2105446000', 'https://openalex.org/W2104736692', 'https://openalex.org/W2083103535', 'https://openalex.org/W2032208061', 'https://openalex.org/W2030111839', 'https://openalex.org/W2015441944', 'https://openalex.org/W2010497382', 'https://openalex.org/W2001632090', 'https://openalex.org/W1604494817'], 'abstract_inverted_index': {'The': [0, 91], 'interaction': [1, 142, 160], 'between': [2, 146], 'verapamil,': [3], 'a': [4, 87, 179], 'P-glycoprotein': [5], '(P-gp)': [6], 'inhibitor,': [7], 'with': [8], 'ritonavir': [9, 80, 98, 107, 149], 'and': [10, 15, 49, 53, 58, 76, 79, 99, 116, 148, 167], 'lopinavir/ritonavir': [11], '(LPV/r)': [12], 'after': [13, 70, 154, 164], 'acute': [14, 114, 123, 165], 'chronic': [16, 117], 'treatment': [17, 118], 'was': [18, 101, 143], 'investigated': [19], 'in': [20, 189], 'rats.': [21], 'Rats': [22], 'were': [23, 68, 83], 'divided': [24], 'into': [25], '4': [26], 'groups,': [27], 'viz.': [28], 'Group': [29], '1:': [30], 'ritonavir,': [31, 37], '20': [32, 38, 50, 59], 'mg/kg/d': [33, 39, 43, 51, 60, 64], '(n=18),': [34, 44], 'group': [35, 45, 54], '2:': [36], 'plus': [40, 61], 'verapamil': [41, 62, 129, 147], '5': [42, 63], '3:': [46], 'LPV/r,': [47, 56], '80': [48, 57], '(n=17)': [52], '4:': [55], '(n=18).': [65], 'Blood': [66], 'samples': [67], 'collected': [69], 'decapitation': [71], 'on': [72], 'days': [73], '1,': [74], '7': [75], '21.': [77], 'Lopinavir': [78], 'plasma': [81, 108], 'levels': [82, 134], 'simultaneous': [84], 'determined': [85], 'by': [86], 'validated': [88], 'LC/MS/MS': [89], 'method.': [90], 'lower': [92], 'limit': [93], 'of': [94, 178], 'quantification': [95], 'for': [96], 'both': [97], 'lopinavir': [100, 133], '0.078': [102], 'µg/ml.': [103], 'Verapamil': [104], 'significantly': [105], 'increased': [106, 131], 'levels,': [109], 'administered': [110, 151], 'as': [111], 'monotherapy,': [112], 'following': [113], '(p<0.005)': [115], '(day': [119], '21)': [120], '(p<0.005).': [121], 'During': [122], '(but': [124], 'not': [125], 'chronic)': [126], 'LPV/r': [127], 'treatment,': [128, 166], 'also': [130], 'the': [132, 155, 176], '(p<0.05).': [135], 'A': [136], 'time': [137, 181], 'or': [138, 153], 'exposure': [139], 'dependent': [140], 'pharmacokinetic': [141], 'thus': [144], 'observed': [145], 'whether': [150], 'alone': [152], 'lopinavir-ritonavir': [156], 'combination': [157], '(LPV/r).': [158], 'This': [159, 173], 'occurred': [161], 'most': [162], 'prominently': [163], 'became': [168], 'less': [169], 'pronounced': [170], 'over': [171], 'time.': [172], 'study': [174], 'indicates': [175], 'importance': [177], 'longer': [180], 'frame': [182], 'to': [183], 'investigate': [184], 'enzyme': [185], 'based': [186], 'drug': [187], 'interactions': [188], 'rat': [190], 'models.': [191]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2112515627', 'counts_by_year': [{'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-13T18:36:53.486178', 'created_date': '2016-06-24'}